Literature DB >> 1760422

Gamete intrafallopian transfer (GIFT) compared with intrauterine insemination in the treatment of unexplained infertility.

A P Murdoch1, M Harris, M Mahroo, M Williams, W Dunlop.   

Abstract

OBJECTIVE: To compare GIFT, intrauterine insemination (IUI) with, and without, ovarian hyperstimulation in the treatment of unexplained infertility.
DESIGN: Women randomly allocated to one of three treatment protocols.
SETTING: Northern Regional Fertility Centre.
SUBJECTS: 59 couples with unexplained infertility of more than 3 years duration.
INTERVENTIONS: Three cycles of either GIFT, IUI after ovarian hyperstimulation or IUI in a spontaneous cycle. MAIN OUTCOME MEASURES: Pregnancy resulting in a live birth.
RESULTS: Fecundabilities were 0.12 after GIFT, 0.018 after ovarian hyperstimulation and IUI, and 0.018 after IUI in a spontaneous cycle. The fecundability after IUI was no different from that which would be expected without treatment in these couples but fecundability was significantly better (P greater than 0.02) after GIFT.
CONCLUSIONS: This trial does not support the use of IUI in the treatment of unexplained infertility but confirms the value of GIFT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760422     DOI: 10.1111/j.1471-0528.1991.tb15362.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  3 in total

1.  IVF versus GIFT.

Authors:  I Craft; T al-Shawaf
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Interventions for unexplained infertility: a systematic review and network meta-analysis.

Authors:  Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

3.  Intra-uterine insemination for unexplained subfertility.

Authors:  Reuben Olugbenga Ayeleke; Joyce Danielle Asseler; Ben J Cohlen; Susanne M Veltman-Verhulst
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.